Last updated: February 19, 2025
Sponsor: Beijing Anzhen Hospital
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Arrhythmia
Chest Pain
Atrial Fibrillation
Treatment
intervention group
Clinical Study ID
NCT06842160
KS2024101
KS2024101
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Atrial fibrillation patients diagnosed by electrocardiogram
Received catheter ablation procedure
Willing to use long-range electrocardiogram monitoring equipment
Exclusion
Exclusion Criteria:
1.Patients who are allergic to electronic devices or unable to wear watches
Study Design
Total Participants: 10000
Treatment Group(s): 1
Primary Treatment: intervention group
Phase:
Study Start date:
March 30, 2025
Estimated Completion Date:
March 30, 2036
Connect with a study center
Beijing Anzhen Hospital
Beijing, Beijing 100000
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.